News
First carbetocin prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: RH095 - Carbetocin - 100mcg/ml - Solution for injection - Ferring International Center SA - SWITZERLAND Related...
Collaborative Registration Procedure (CRP) Workshops
Two virtual CRP Advocacy and Sensitization Workshops were held in partnership with WHO Regional Offices: PAHO-AFRO 8-10 June 2022 and EMRO-SEARO-WPRO 14-16 June 2022. The objective of these workshops...
Emergency Use Listing (EUL) Workshop
In partnership with the WHO Country Office in Turkey the PQ Team held an EUL Workshop on the 28 April 2022 with IVD regulators from the national regulatory authority TITCK and IVD manufacturers based...
PQ Guidance documents
Continuing its efforts to support prequalification applicants and increase transparency, PQT has started developing Technical Specifications for glucose meters and HbA1c POC IVDs. Later in the year...
COVID-19 Pandemic and Emergency Use Listing (EUL)
Emergency Use Listing (EUL) for candidate in vitro diagnostics (IVDs) to detect SARS-CoV-2 remains ongoing. WHO has expanded the scope of EUL to include SARS-CoV-2 AgRDTs intended for self-testing...
Hetero’s efavirenz/lamivudine/tenofovir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: HA759 - Efavirenz/Lamivudine/Tenofovir disoproxil fumarate - 400mg/300mg/300mg - Film-coated tablet - Hetero Labs...
Micro Labs’ efavirenz/lamivudine/tenofovir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: HA767 - Efavirenz/Lamivudine/Tenofovir disoproxil fumarate - 600mg/300mg/300mg - Film-coated tablet - Micro Labs...